| [1] |
ZHANG Yan, CHEN Tongzhen, ZHU Xiaoli, LI Xiaoqiu.
Analysis of clinicopathological features of human papilloma virus-associated oropharyngeal squamous cell carcinoma
[J]. China Oncology, 2022, 32(1): 47-53.
|
| [2] |
ZHANG Chi, CHEN Jiahui, LIN Jinyi, WANG Yan, ZHANG Sijia, ZHU Wei, CHENG Leilei.
Validation of a scale for evaluating the cardiovascular risk after breast cancer therapy: the clinical scale for breast cancer treatment related cardiovascular toxicity
[J]. China Oncology, 2022, 32(1): 54-60.
|
| [3] |
JIN Yizi, LIN Mingxi, ZHANG Jian.
Targeting DNA damage response deficiency in the treatment of breast cancer
[J]. China Oncology, 2022, 32(1): 61-67.
|
| [4] |
Expert group of expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition) .
Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
[J]. China Oncology, 2022, 32(1): 80-89.
|
| [5] |
XU Ran , WANG Xinyue , FENG Linyuan , HAN Anna , WANG Yixuan , YANG Wanshan , LIU Chao .
Expression and biological significance of NCAPD2 in glioma
[J]. China Oncology, 2021, 31(9): 789-798.
|
| [6] |
LU Li, LU Renquan, SUN Jiajun, LU Ning, GUO Lin.
The application of serum N-MID in auxiliary diagnosis and therapeutic effect monitoring of bone metastasis in patients with primary lung cancer
[J]. China Oncology, 2021, 31(9): 838-844.
|
| [7] |
Tumor Support and Rehabilitation Therapy Group, the Oncology Committee of Chinese Medical Association.
Clinical practice guidelines for cancer-related fatigue in China (2021 edition)
[J]. China Oncology, 2021, 31(9): 852-872.
|
| [8] |
GAO Heli, XU Jin, YU Xianjun.
Advances in clinical diagnosis and treatment of gastroenteropancreatic neuroendocrine tumor G3
[J]. China Oncology, 2021, 31(7): 567-573.
|
| [9] |
FENG Runlin , HUA Jie , KUI Xiang , LI Ruyi , YI Xiaojia , WANG Yan , TAO Yanping .
A case report of metastatic pericardial myxoid liposarcoma and literature review
[J]. China Oncology, 2021, 31(3): 227-230.
|
| [10] |
ZHOU Hongyu , LI Haoran , CHENG Xi , CHEN Lihua , YANG Yufei , CHANG Bin .
Clinical characteristics of 11 patients with small cell carcinoma of the ovary, hypercalcemic type and literature review
[J]. China Oncology, 2021, 31(2): 136-142.
|
| [11] |
YOU Chao , ZHENG Huizhong , JIANG Tingting , JIAN Jiahao , FAN Ming , LI Lihua , WU Jiong , GU Yajia , PENG Weijun .
Differential diagnosis of mass lesions in digital breast tomosynthesis based on radiomics
[J]. China Oncology, 2021, 31(12): 1162-1167.
|
| [12] |
LI Zeng , WU Yi , CHEN Zhuzhong , CHEN Li , LIAO Hong , MAO Dun , XIAO Yingming , XIE Hongping , LI Xiuli , YANG Shengke , ZHOU Shukui , ZHONG Lei , LU Hao , CHEN Yongji .
The value of 18 F-PSMA-1007 PET/CT in the early diagnosis and clinical treatment of patients with biochemical recurrence after radical prostatectomy
[J]. China Oncology, 2021, 31(11): 1081-1087.
|
| [13] |
XU Yitian, HUANG Chen.
Research advances in the early diagnosis of gastric cancer of non-blood derived liquid biopsy
[J]. China Oncology, 2021, 31(10): 936-943.
|
| [14] |
BAO Lingjie , NING Yan , YI Xiaofang .
Synchronous primary fallopian tube and endometrial cancers: a report of three cases and literature review
[J]. China Oncology, 2021, 31(10): 949-953.
|
| [15] |
LI Zeng, LIAO Hong, MAO Dun, WU Yi, XIAO Yingming, YANG Shengke, ZHONG Lei, ZHOU Shukui, CHEN Yongji.
The value of 18 F-PSMA-1007 PET/CT in accurate assessment of newly diagnosed prostate cancer and its impact on clinical treatment decisions
[J]. China Oncology, 2020, 30(3): 231-236.
|
